PRIO WEALTH LIMITED PARTNERSHIP - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 57 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRIO WEALTH LIMITED PARTNERSHIP ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$26,000
-25.7%
12,8950.0%0.00%
-50.0%
Q1 2019$35,000
-10.3%
12,8950.0%0.00%0.0%
Q4 2018$39,000
-45.1%
12,8950.0%0.00%
-33.3%
Q3 2018$71,000
-13.4%
12,8950.0%0.00%
-25.0%
Q2 2018$82,000
-8.9%
12,8950.0%0.00%0.0%
Q1 2018$90,000
-32.8%
12,8950.0%0.00%
-33.3%
Q4 2017$134,000
+14.5%
12,8950.0%0.01%0.0%
Q3 2017$117,00012,8950.01%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,200,000$7,692,0001.99%
BIEGEL & WALLER LLC 66,508$426,0000.26%
683 Capital Management, LLC 500,000$3,205,0000.22%
Artal Group S.A. 500,000$3,205,0000.07%
BSW Wealth Partners 22,236$143,0000.06%
Aveo Capital Partners, LLC 16,732$107,0000.05%
ATLAS CAPITAL ADVISORS LLC 12,891$92,300,0000.03%
Radnor Capital Management, LLC 10,000$64,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 173,686$1,113,0000.02%
Engineers Gate Manager LP 16,565$106,0000.01%
View complete list of MIRAGEN THERAPEUTICS INC shareholders